FDA Inspection 706100 — Cobrek Pharmaceuticals Inc
The FDA completed an inspection of Cobrek Pharmaceuticals Inc on Jan 5, 2011 in Chicago, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 5, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chicago, IL (United States)